A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/14623956

Proc. Natl. Acad. Sci. U.S.A. 2003 Nov 25 100 24 14036-41

Download in:

View as

Triples

General Info

PMID
14623956